Based on all the negative publicity surrounding the FDA warning on June 16, 2009, will Matrixx Initiatives, makers of Zicam, go out of business?
The FDA warning letter could present a significant challenge for Matrixx Initiatives, Inc. and impact the business in two regards (1) impact to the Zicam brand and its equity (it was one of the fastest growing brands in the medicine aisle over the past decade) and (2) cost of unwarrantedlitigation. We can’t assess at this time the full financial impact of this situation, but we are optimistic that even without our two Zicam intranasal products we can continue to have a successful business. In fact, we will be launching two new unique oral forms of Cold Remedy for this upcoming cold and flu season.
Related Questions
- Based on all the negative publicity surrounding the FDA warning on June 16, 2009, will Matrixx Initiatives, makers of Zicam, go out of business?
- What current Zicam products have been affected by the FDA’s recent warning letter to Matrixx Initiatives?
- Do any UK based artists or craft makers use these with online shops to sell their work?
